Serum and Salivary Matrix Metalloproteinases, Neutrophil Elastase, Myeloperoxidase in Patients with Chronic or Aggressive Periodontitis

Inflammation

Volumn 37, Issue 5, 2014, Pages 1771-1778

  Nizam, Nejat ^a   Gümüş, Pınar ^a   Pitkänen, Jari ^b   Tervahartiala, Taina ^b   Sorsa, Timo ^b,c   Buduneli, Nurcan ^a  

^a EGE UNIVERSITY   (Turkey)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

aggressive periodontitis; chronic periodontitis; matrix metalloproteinases; saliva; serum; tissue inhibitor of metalloproteinase 1

Indexed keywords

ELASTASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; BIOLOGICAL MARKER; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; PEROXIDASE;

ADULT; AGGRESSIVE PERIODONTITIS; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CHRONIC PERIODONTITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUOROMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUTROPHIL; PLAQUE INDEX; PROTEIN BLOOD LEVEL; SALIVA ANALYSIS; SALIVA LEVEL; SMOKING; TOOTH PLAQUE; BLOOD; METABOLISM; SALIVA;

ADULT; AGGRESSIVE PERIODONTITIS; BIOLOGICAL MARKERS; CHRONIC PERIODONTITIS; FEMALE; HUMANS; LEUKOCYTE ELASTASE; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PEROXIDASE; SALIVA;

EID: 84918832511     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9907-0     Document Type: Article

References (36)

1. Armitage, G.C. 2004. Periodontal diagnoses and classification of periodontal diseases. Periodontology 2000 34: 9–21.
2. Albandar, J.M., and E.M. Tinoco. 2002. Global epidemiology of periodontal diseases in children and young persons. Periodontology 2000 29: 153–176.
3. Demmer, R.T., and P.N. Papapanou. 2010. Epidemiologic patterns of chronic and aggressive periodontitis. Periodontology 2000 53: 28–44.
4. Sorsa, T., L. Tjaderhane, and T. Salo. 2004. Matrix metalloproteinases (MMPs) in oral diseases. Oral Diseases 10: 311–318.
5. Sorsa, T., L. Tjaderhane, Y.T. Konttinen, et al. 2006. Matrix metalloproteinases: Contribution to pathogenesis and treatment of periodontal inflammation. Annals of Medicine 38: 306–321.
6. Kuula, H., T. Salo, E. Pirilä, et al. 2009. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infection and Immunity 77: 850–859.
7. Howard, E.W., E.C. Bullen, and M.J. Banda. 1991. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinasees-2. Journal of Biological Chemistry 266: 13070–13075.
8. Aiba, T., N. Akeno, T. Kawane, H. Okamoto, and N. Horiuchi. 1996. Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. European Journal of Oral Sciences 104: 562–569.
9. Bıyıkoğlu, B., N. Buduneli, L. Kardeşler, K. Aksu, M. Pitkala, and T. Sorsa. 2009. Gingival crevicular fluid matrix metalloproteinase-8, -13 and tissue inhibitor of matrix metalloproteinase-1 levels in rheumatoid arthritis patients with inflammatory periodontal disease. Journal of Periodontology 80: 1307–1316.
10. Geraghty, P., M.P. Rogan, C.M. Greene, et al. 2007. Neutrophil elastase up-regulates cathepsin B and matrix metalloproteinase-2 expression. Journal of Immunology 178: 5871–5878.
11. Kawabata, K., T. Hagio, and S. Matsuoka. 2002. The role of neutrophil elastase in acute lung injury. European Journal of Pharmacology 451: 1–10.
12. Buchmann, R., A. Hasilik, M.E. Nunn, T.E. Van Dyke, and D.E. Lange. 2002. PMN responses in chronic periodontal disease: Evaluation by gingival crevicular fluid enzymes and elastase-alpha-1-proteinase inhibitor complex. Journal of Clinical Periodontology 29: 563–572.
13. Smith, M., G.J. Seymour, and M.P. Cullinan. 2010. Histopathological features of chronic and aggressive periodontitis. Periodontology 2000 53: 45–54.
14. Armitage, G.C. 2010. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontology 2000 53: 70–88.
15. Nibali, L., M. Parkar, P. Brett, J. Knight, M.S. Tonetti, and G.S. Griffiths. 2006. NADPH oxidase (CYBA) and FcgR polymorphisms as risk factors for aggressive periodontitis: A case–control association study. Journal of Clinical Periodontology 33: 529–539.
16. Erley, K.J., G.D. Swiec, R. Herold, F.C. Bisch, and M.E. Peacock. 2006. Gingival recession treatment with connective tissue grafts in smokers and non-smokers. Journal of Periodontology 77: 1148–1155.
17. Armitage, G.C. 1999. Development of a classification system for periodontal diseases and conditions. Annals of Periodontology 4: 1–6.
18. Navazesh, M. 1993. Methods for collecting saliva. Annals of the New York Academy of Sciences 694: 72–77.
19. Quigley, G., and J. Hein. 1962. Comparative cleansing efficiency of manual and power brushing. Journal of the American Dental Association 65: 26–29.
20. Hanemaaijer, R., T. Sorsa, Y.T. Konttinen, et al. 1997. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. Journal of Biological Chemistry 272: 31504–31509.
21. Tuomainen, A.M., K. Nyyssonen, J.A. Laukkanen, et al. 2007. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 2722–2728.
22. Lauhio, A., T. Salo, Y. Ding, Y.T. Konttinen, D. Nordström, H. Tschesche, J. Lähdevirta, L.M. Golub, and T. Sorsa. 1994. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clinical and Experimental Immunology 98: 21–28.
23. Rautelin, H.I., A.M. Oksanen, L.I. Veijola, et al. 2009. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis. Annals of Medicine 41: 208–215.
24. Cole, A.A., S. Chubinskaya, B. Schumacher, et al. 1996. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. Journal of Biological Chemistry 271: 11023–11026.
25. Ozcaka, O., N. Bicakci, P. Pussinen, T. Sorsa, T. Kose, and N. Buduneli. 2011. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Diseases 17: 68–76.
26. Cairo, F., M. Nieri, A.M. Gori, et al. 2010. Markers of systemic inflammation in periodontal patients: Chronic versus aggressive periodontitis. An exploratory cross-sectional study. European Journal of Oral Implantology 3: 147–153.
27. Wohlfeil, M., S. Scharf, Y. Siegelin, et al. 2012. Increased systemic elastase and C-reactive protein in aggressive periodontitis. Clinical Oral Investigations 16: 1199–1207.
28. Duarte, P.M., M. da Rocha, E. Sampaio, et al. 2010. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: A pilot study. Journal of Periodontology 81: 1056–1063.
29. Sorsa, T., P. Mäntylä, H. Rönkä, et al. 1999. Scientific basis of matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Annals of the New York Academy of Sciences 878: 130–140.
30. Said, S., H. Mohd, L. Sander, H. Ronka, T. Sorsa, and D.F. Kinane. 1999. GCF levels of MMP-3 and MMP-8 following placement of bioresorbable membranes. Journal of Clinical Periodontology 26: 757–763.
31. Meschiari, C.A., A.M. Marcaccini, B.C. Santos Moura, L.R. Zuardi, J.E. Tanus-Santos, and R.F. Gerlach. 2013. Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls. Clinica Chimica Acta 421: 140–146.
32. Ujiie, Y., S. Oida, K. Gomi, T. Arai, and M. Fukae. 2007. Neutrophil elastase is involved in the initial destruction of human periodontal ligament. Journalof Periodontal Research 42: 325–330.
33. Wohlfeil, M., J. Wehner, B. Schacher, G.M. Oremek, H. Sauer-Eppel, and P. Eickholz. 2009. Degree of gingivitis correlates to systemic inflammation markers. Clinica Chimica Acta 401: 105–109.
34. Buduneli, N., S. Vardar, G. Atilla, T. Sorsa, H. Luoto, and H. Baylas. 2002. Ginvival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. Journal of Periodontology 73: 103–109.
35. Rathnayake, N., S. Akerman, B. Klinge, N. Lundegren, H. Jansson, Y. Tryselius, T. Sorsa, and A. Gustafsson. 2013. Salivary biomarkers of oral health—A cross-sectional study. Journal of Clinical Periodontology 40: 140–147.
36. Gursoy, U.K., E. Könönen, S. Huumonen, T. Tervahartiala, P.J. Pussinen, A.L. Suominen, and T. Sorsa. 2013. Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. Journal of Clinical Periodontology 40: 18–25.